US approves Emergent's smallpox vaccine for people at high risk of mpox

A test tube labelled "Mpox virus positive" is held in this illustration taken August 20, 2024. — Reuters In a bid to deal with mpox infection, the US Food and Drug Administration approved expanded use of Emergent BioSolutions' EBS.N ACAM2000 smallpox vaccine to include people at high...

Post a Comment

0 Comments
* Please Don't Spam Here. All the Comments are Reviewed by Admin.